http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2419993-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6abe8f4287ebbb10ee4e7ddb8eb0e40a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2001-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb1ac54981f9c847a29fd4a9b61dc1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f0189f5868191dc9954e9c230690691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4802250b2c689430b75e8f86b16ad92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16474bfe72291318a561cb4c7ac68b8a
publicationDate 2002-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2419993-A1
titleOfInvention Process for preparing pharmaceutical compositions for use with soft gelatin formulations
abstract The invention disclosed herein is a process for increasing the achievable concentration of a pharmaceutically active ingredient relative to fill composition viscosity for dosage units. The process is particularly useful in the preparation of soft gelatin capsules containing ibuprofen, naproxen, indomethacin, and acetaminophen, as the pharmaceutically active ingredient. As a result of the process, lesser quantities of composition ingredients other than the pharmaceutically active ingredient are needed to accomplish the same therapeutically effective dosage, thereby significantly increasing the concentration of the pharmaceutically active ingredient resulting in either a reduction in overall fill volume and dosage unit size or an increase in concentration of pharmaceutically active ingredient per dosage form.
priorityDate 2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597

Total number of triples: 31.